B. Nezami

Molecular features of prostate cancer with neuroendocrine differentiation.

Prostate cancer (PCa) is a biologically diverse malignancy with a clinical trajectory that often culminates in treatment resistance and aggressive phenotypes. Among these, neuroendocrine prostate cancer (NEPC) represents a particularly lethal variant that arises either de novo or through transdifferentiation from conve...